Target intelligence / Profile preview

Potassium channel tetramerization domain containing 9 pseudogene 5 (KCTD9P5)

Target
KCTD9P5
Molecular classification
Pseudogene, Other (not a functional protein, not a typical drug target class)
01

Overview

Potassium channel tetramerization domain containing 9 pseudogene 5 (KCTD9P5) is classified as a processed pseudogene in the human genome and does not encode a functional protein. It shares sequence similarity with KCTD9, a gene encoding a member of the potassium channel tetramerization domain-containing protein family. As a pseudogene, KCTD9P5 is not known to function as an ion channel, receptor, or other canonical drug target. Some pseudogenes can have biological activity as non-coding RNAs affecting the expression of related genes, but there are no data indicating such a function for KCTD9P5 specifically. KCTD9P5 is a pseudogene, not a functional protein-coding gene. It is not considered a therapeutic target (receptor, enzyme, transporter, etc.) since it does not produce a functional molecule. No known disease associations, biomarkers, drug interactions, or mechanisms of action. No aliases were found in the main databases.

02

Biological functions

Possible regulation of coding gene expression via non-coding RNA mechanisms in some pseudogenes
03

Disease associations

Other (pseudogenes may regulate disease-related genes, but no direct evidence for KCTD9P5 involvement)

Beyond the preview

Go deeper on Potassium channel tetramerization domain containing 9 pseudogene 5 (KCTD9P5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium channel tetramerization domain containing 9 pseudogene 5 (KCTD9P5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call